nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—Erectile dysfunction—Prednisone—systemic scleroderma	0.000343	0.000343	CcSEcCtD
Cevimeline—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000343	0.000343	CcSEcCtD
Cevimeline—Feeling abnormal—Leflunomide—systemic scleroderma	0.000342	0.000342	CcSEcCtD
Cevimeline—Fatigue—Mycophenolic acid—systemic scleroderma	0.000341	0.000341	CcSEcCtD
Cevimeline—Mood swings—Methotrexate—systemic scleroderma	0.000341	0.000341	CcSEcCtD
Cevimeline—Nausea—Mometasone—systemic scleroderma	0.000341	0.000341	CcSEcCtD
Cevimeline—Anorexia—Lisinopril—systemic scleroderma	0.00034	0.00034	CcSEcCtD
Cevimeline—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Cevimeline—Weight increased—Prednisone—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Cevimeline—Pain—Mycophenolic acid—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Cevimeline—Constipation—Mycophenolic acid—systemic scleroderma	0.000339	0.000339	CcSEcCtD
Cevimeline—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000338	0.000338	CcSEcCtD
Cevimeline—Weight decreased—Prednisone—systemic scleroderma	0.000337	0.000337	CcSEcCtD
Cevimeline—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Cevimeline—Hyperglycaemia—Prednisone—systemic scleroderma	0.000336	0.000336	CcSEcCtD
Cevimeline—Cough—Mycophenolate mofetil—systemic scleroderma	0.000334	0.000334	CcSEcCtD
Cevimeline—Hypotension—Lisinopril—systemic scleroderma	0.000333	0.000333	CcSEcCtD
Cevimeline—Dizziness—Captopril—systemic scleroderma	0.000333	0.000333	CcSEcCtD
Cevimeline—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000332	0.000332	CcSEcCtD
Cevimeline—Depression—Prednisone—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Cevimeline—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000331	CcSEcCtD
Cevimeline—Urticaria—Leflunomide—systemic scleroderma	0.00033	0.00033	CcSEcCtD
Cevimeline—Abdominal pain—Leflunomide—systemic scleroderma	0.000328	0.000328	CcSEcCtD
Cevimeline—Body temperature increased—Leflunomide—systemic scleroderma	0.000328	0.000328	CcSEcCtD
Cevimeline—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000327	0.000327	CcSEcCtD
Cevimeline—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000326	0.000326	CcSEcCtD
Cevimeline—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000326	0.000326	CcSEcCtD
Cevimeline—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000326	0.000326	CcSEcCtD
Cevimeline—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000326	0.000326	CcSEcCtD
Cevimeline—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000326	0.000326	CcSEcCtD
Cevimeline—Myocardial infarction—Prednisone—systemic scleroderma	0.000326	0.000326	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Cevimeline—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000325	0.000325	CcSEcCtD
Cevimeline—Hypersensitivity—Azathioprine—systemic scleroderma	0.000324	0.000324	CcSEcCtD
Cevimeline—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000324	0.000324	CcSEcCtD
Cevimeline—Insomnia—Lisinopril—systemic scleroderma	0.000323	0.000323	CcSEcCtD
Cevimeline—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000322	0.000322	CcSEcCtD
Cevimeline—Paraesthesia—Lisinopril—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Cevimeline—Vomiting—Captopril—systemic scleroderma	0.00032	0.00032	CcSEcCtD
Cevimeline—Dyspnoea—Lisinopril—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Cevimeline—Rash—Captopril—systemic scleroderma	0.000318	0.000318	CcSEcCtD
Cevimeline—Dermatitis—Captopril—systemic scleroderma	0.000317	0.000317	CcSEcCtD
Cevimeline—Somnolence—Lisinopril—systemic scleroderma	0.000317	0.000317	CcSEcCtD
Cevimeline—Headache—Captopril—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Cevimeline—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000315	0.000315	CcSEcCtD
Cevimeline—Dyspepsia—Lisinopril—systemic scleroderma	0.000314	0.000314	CcSEcCtD
Cevimeline—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Cevimeline—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000313	0.000313	CcSEcCtD
Cevimeline—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000312	0.000312	CcSEcCtD
Cevimeline—Asthma—Methotrexate—systemic scleroderma	0.000311	0.000311	CcSEcCtD
Cevimeline—Infection—Mycophenolate mofetil—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Cevimeline—Decreased appetite—Lisinopril—systemic scleroderma	0.00031	0.00031	CcSEcCtD
Cevimeline—Eosinophilia—Methotrexate—systemic scleroderma	0.000308	0.000308	CcSEcCtD
Cevimeline—Fatigue—Lisinopril—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Cevimeline—Shock—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000307	CcSEcCtD
Cevimeline—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Cevimeline—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Cevimeline—Hypersensitivity—Leflunomide—systemic scleroderma	0.000306	0.000306	CcSEcCtD
Cevimeline—Pain—Lisinopril—systemic scleroderma	0.000305	0.000305	CcSEcCtD
Cevimeline—Constipation—Lisinopril—systemic scleroderma	0.000305	0.000305	CcSEcCtD
Cevimeline—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000305	0.000305	CcSEcCtD
Cevimeline—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000303	0.000303	CcSEcCtD
Cevimeline—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000302	CcSEcCtD
Cevimeline—Diarrhoea—Azathioprine—systemic scleroderma	0.000301	0.000301	CcSEcCtD
Cevimeline—Haemoglobin—Prednisone—systemic scleroderma	0.0003	0.0003	CcSEcCtD
Cevimeline—Nausea—Captopril—systemic scleroderma	0.000299	0.000299	CcSEcCtD
Cevimeline—Haemorrhage—Prednisone—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Cevimeline—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Cevimeline—Asthenia—Leflunomide—systemic scleroderma	0.000298	0.000298	CcSEcCtD
Cevimeline—Hallucination—Prednisone—systemic scleroderma	0.000297	0.000297	CcSEcCtD
Cevimeline—Feeling abnormal—Lisinopril—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Cevimeline—Pruritus—Leflunomide—systemic scleroderma	0.000294	0.000294	CcSEcCtD
Cevimeline—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Cevimeline—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000292	0.000292	CcSEcCtD
Cevimeline—Dysuria—Methotrexate—systemic scleroderma	0.000291	0.000291	CcSEcCtD
Cevimeline—Dizziness—Azathioprine—systemic scleroderma	0.000291	0.000291	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000289	0.000289	CcSEcCtD
Cevimeline—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000287	0.000287	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000285	0.000285	CcSEcCtD
Cevimeline—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Cevimeline—Asthenia—Mycophenolic acid—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Cevimeline—Diarrhoea—Leflunomide—systemic scleroderma	0.000284	0.000284	CcSEcCtD
Cevimeline—Urticaria—Lisinopril—systemic scleroderma	0.000283	0.000283	CcSEcCtD
Cevimeline—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000283	0.000283	CcSEcCtD
Cevimeline—Abdominal pain—Lisinopril—systemic scleroderma	0.000282	0.000282	CcSEcCtD
Cevimeline—Body temperature increased—Lisinopril—systemic scleroderma	0.000282	0.000282	CcSEcCtD
Cevimeline—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000281	0.000281	CcSEcCtD
Cevimeline—Pruritus—Mycophenolic acid—systemic scleroderma	0.00028	0.00028	CcSEcCtD
Cevimeline—Vomiting—Azathioprine—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Cevimeline—Pneumonia—Methotrexate—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Cevimeline—Eye disorder—Prednisone—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Cevimeline—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000279	CcSEcCtD
Cevimeline—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000278	0.000278	CcSEcCtD
Cevimeline—Rash—Azathioprine—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Cevimeline—Dermatitis—Azathioprine—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Cevimeline—Depression—Methotrexate—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Cevimeline—Flushing—Prednisone—systemic scleroderma	0.000277	0.000277	CcSEcCtD
Cevimeline—Headache—Azathioprine—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Cevimeline—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000275	0.000275	CcSEcCtD
Cevimeline—Dizziness—Leflunomide—systemic scleroderma	0.000274	0.000274	CcSEcCtD
Cevimeline—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000272	0.000272	CcSEcCtD
Cevimeline—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000271	0.000271	CcSEcCtD
Cevimeline—Stomatitis—Methotrexate—systemic scleroderma	0.000271	0.000271	CcSEcCtD
Cevimeline—Angiopathy—Prednisone—systemic scleroderma	0.00027	0.00027	CcSEcCtD
Cevimeline—Conjunctivitis—Methotrexate—systemic scleroderma	0.00027	0.00027	CcSEcCtD
Cevimeline—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Cevimeline—Pain—Mycophenolate mofetil—systemic scleroderma	0.000267	0.000267	CcSEcCtD
Cevimeline—Arrhythmia—Prednisone—systemic scleroderma	0.000266	0.000266	CcSEcCtD
Cevimeline—Haematuria—Methotrexate—systemic scleroderma	0.000265	0.000265	CcSEcCtD
Cevimeline—Vomiting—Leflunomide—systemic scleroderma	0.000264	0.000264	CcSEcCtD
Cevimeline—Alopecia—Prednisone—systemic scleroderma	0.000263	0.000263	CcSEcCtD
Cevimeline—Hypersensitivity—Lisinopril—systemic scleroderma	0.000263	0.000263	CcSEcCtD
Cevimeline—Dizziness—Mycophenolic acid—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Cevimeline—Epistaxis—Methotrexate—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Cevimeline—Rash—Leflunomide—systemic scleroderma	0.000262	0.000262	CcSEcCtD
Cevimeline—Dermatitis—Leflunomide—systemic scleroderma	0.000261	0.000261	CcSEcCtD
Cevimeline—Nausea—Azathioprine—systemic scleroderma	0.000261	0.000261	CcSEcCtD
Cevimeline—Headache—Leflunomide—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Cevimeline—Malnutrition—Prednisone—systemic scleroderma	0.00026	0.00026	CcSEcCtD
Cevimeline—Agranulocytosis—Methotrexate—systemic scleroderma	0.000259	0.000259	CcSEcCtD
Cevimeline—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000257	0.000257	CcSEcCtD
Cevimeline—Asthenia—Lisinopril—systemic scleroderma	0.000256	0.000256	CcSEcCtD
Cevimeline—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000256	0.000256	CcSEcCtD
Cevimeline—Pruritus—Lisinopril—systemic scleroderma	0.000252	0.000252	CcSEcCtD
Cevimeline—Vomiting—Mycophenolic acid—systemic scleroderma	0.000252	0.000252	CcSEcCtD
Cevimeline—Haemoglobin—Methotrexate—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Cevimeline—Rash—Mycophenolic acid—systemic scleroderma	0.00025	0.00025	CcSEcCtD
Cevimeline—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Cevimeline—Haemorrhage—Methotrexate—systemic scleroderma	0.000249	0.000249	CcSEcCtD
Cevimeline—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Cevimeline—Headache—Mycophenolic acid—systemic scleroderma	0.000248	0.000248	CcSEcCtD
Cevimeline—Pharyngitis—Methotrexate—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Cevimeline—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Cevimeline—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Cevimeline—Nausea—Leflunomide—systemic scleroderma	0.000247	0.000247	CcSEcCtD
Cevimeline—Urethral disorder—Methotrexate—systemic scleroderma	0.000244	0.000244	CcSEcCtD
Cevimeline—Diarrhoea—Lisinopril—systemic scleroderma	0.000244	0.000244	CcSEcCtD
Cevimeline—Ill-defined disorder—Prednisone—systemic scleroderma	0.000241	0.000241	CcSEcCtD
Cevimeline—Visual impairment—Methotrexate—systemic scleroderma	0.00024	0.00024	CcSEcCtD
Cevimeline—Anaemia—Prednisone—systemic scleroderma	0.00024	0.00024	CcSEcCtD
Cevimeline—Agitation—Prednisone—systemic scleroderma	0.000238	0.000238	CcSEcCtD
Cevimeline—Dizziness—Lisinopril—systemic scleroderma	0.000236	0.000236	CcSEcCtD
Cevimeline—Nausea—Mycophenolic acid—systemic scleroderma	0.000235	0.000235	CcSEcCtD
Cevimeline—Malaise—Prednisone—systemic scleroderma	0.000234	0.000234	CcSEcCtD
Cevimeline—Vertigo—Prednisone—systemic scleroderma	0.000233	0.000233	CcSEcCtD
Cevimeline—Eye disorder—Methotrexate—systemic scleroderma	0.000233	0.000233	CcSEcCtD
Cevimeline—Syncope—Prednisone—systemic scleroderma	0.000233	0.000233	CcSEcCtD
Cevimeline—Tinnitus—Methotrexate—systemic scleroderma	0.000232	0.000232	CcSEcCtD
Cevimeline—Cardiac disorder—Methotrexate—systemic scleroderma	0.000231	0.000231	CcSEcCtD
Cevimeline—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00023	0.00023	CcSEcCtD
Cevimeline—Loss of consciousness—Prednisone—systemic scleroderma	0.000228	0.000228	CcSEcCtD
Cevimeline—Vomiting—Lisinopril—systemic scleroderma	0.000227	0.000227	CcSEcCtD
Cevimeline—Angiopathy—Methotrexate—systemic scleroderma	0.000226	0.000226	CcSEcCtD
Cevimeline—Rash—Lisinopril—systemic scleroderma	0.000225	0.000225	CcSEcCtD
Cevimeline—Convulsion—Prednisone—systemic scleroderma	0.000225	0.000225	CcSEcCtD
Cevimeline—Dermatitis—Lisinopril—systemic scleroderma	0.000225	0.000225	CcSEcCtD
Cevimeline—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Cevimeline—Hypertension—Prednisone—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Cevimeline—Chills—Methotrexate—systemic scleroderma	0.000224	0.000224	CcSEcCtD
Cevimeline—Headache—Lisinopril—systemic scleroderma	0.000223	0.000223	CcSEcCtD
Cevimeline—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Cevimeline—Arthralgia—Prednisone—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Cevimeline—Myalgia—Prednisone—systemic scleroderma	0.000221	0.000221	CcSEcCtD
Cevimeline—Anxiety—Prednisone—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Cevimeline—Alopecia—Methotrexate—systemic scleroderma	0.00022	0.00022	CcSEcCtD
Cevimeline—Discomfort—Prednisone—systemic scleroderma	0.000218	0.000218	CcSEcCtD
Cevimeline—Malnutrition—Methotrexate—systemic scleroderma	0.000217	0.000217	CcSEcCtD
Cevimeline—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000214	CcSEcCtD
Cevimeline—Dysgeusia—Methotrexate—systemic scleroderma	0.000212	0.000212	CcSEcCtD
Cevimeline—Nausea—Lisinopril—systemic scleroderma	0.000212	0.000212	CcSEcCtD
Cevimeline—Oedema—Prednisone—systemic scleroderma	0.000212	0.000212	CcSEcCtD
Cevimeline—Infection—Prednisone—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Cevimeline—Back pain—Methotrexate—systemic scleroderma	0.00021	0.00021	CcSEcCtD
Cevimeline—Shock—Prednisone—systemic scleroderma	0.000208	0.000208	CcSEcCtD
Cevimeline—Nervous system disorder—Prednisone—systemic scleroderma	0.000208	0.000208	CcSEcCtD
Cevimeline—Tachycardia—Prednisone—systemic scleroderma	0.000207	0.000207	CcSEcCtD
Cevimeline—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000207	0.000207	CcSEcCtD
Cevimeline—Skin disorder—Prednisone—systemic scleroderma	0.000206	0.000206	CcSEcCtD
Cevimeline—Hyperhidrosis—Prednisone—systemic scleroderma	0.000205	0.000205	CcSEcCtD
Cevimeline—Anorexia—Prednisone—systemic scleroderma	0.000202	0.000202	CcSEcCtD
Cevimeline—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000201	0.000201	CcSEcCtD
Cevimeline—Anaemia—Methotrexate—systemic scleroderma	0.0002	0.0002	CcSEcCtD
Cevimeline—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000199	CcSEcCtD
Cevimeline—Rash—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Cevimeline—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000197	0.000197	CcSEcCtD
Cevimeline—Headache—Mycophenolate mofetil—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Cevimeline—Malaise—Methotrexate—systemic scleroderma	0.000196	0.000196	CcSEcCtD
Cevimeline—Vertigo—Methotrexate—systemic scleroderma	0.000195	0.000195	CcSEcCtD
Cevimeline—Leukopenia—Methotrexate—systemic scleroderma	0.000194	0.000194	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000193	0.000193	CcSEcCtD
Cevimeline—Insomnia—Prednisone—systemic scleroderma	0.000192	0.000192	CcSEcCtD
Cevimeline—Paraesthesia—Prednisone—systemic scleroderma	0.00019	0.00019	CcSEcCtD
Cevimeline—Cough—Methotrexate—systemic scleroderma	0.000189	0.000189	CcSEcCtD
Cevimeline—Convulsion—Methotrexate—systemic scleroderma	0.000188	0.000188	CcSEcCtD
Cevimeline—Dyspepsia—Prednisone—systemic scleroderma	0.000186	0.000186	CcSEcCtD
Cevimeline—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000186	CcSEcCtD
Cevimeline—Arthralgia—Methotrexate—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Cevimeline—Chest pain—Methotrexate—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Cevimeline—Myalgia—Methotrexate—systemic scleroderma	0.000185	0.000185	CcSEcCtD
Cevimeline—Decreased appetite—Prednisone—systemic scleroderma	0.000184	0.000184	CcSEcCtD
Cevimeline—Fatigue—Prednisone—systemic scleroderma	0.000183	0.000183	CcSEcCtD
Cevimeline—Discomfort—Methotrexate—systemic scleroderma	0.000182	0.000182	CcSEcCtD
Cevimeline—Constipation—Prednisone—systemic scleroderma	0.000181	0.000181	CcSEcCtD
Cevimeline—Confusional state—Methotrexate—systemic scleroderma	0.000178	0.000178	CcSEcCtD
Cevimeline—Infection—Methotrexate—systemic scleroderma	0.000176	0.000176	CcSEcCtD
Cevimeline—Feeling abnormal—Prednisone—systemic scleroderma	0.000175	0.000175	CcSEcCtD
Cevimeline—Nervous system disorder—Methotrexate—systemic scleroderma	0.000174	0.000174	CcSEcCtD
Cevimeline—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000173	0.000173	CcSEcCtD
Cevimeline—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000173	0.000173	CcSEcCtD
Cevimeline—Skin disorder—Methotrexate—systemic scleroderma	0.000172	0.000172	CcSEcCtD
Cevimeline—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000171	0.000171	CcSEcCtD
Cevimeline—Anorexia—Methotrexate—systemic scleroderma	0.000169	0.000169	CcSEcCtD
Cevimeline—Urticaria—Prednisone—systemic scleroderma	0.000168	0.000168	CcSEcCtD
Cevimeline—Abdominal pain—Prednisone—systemic scleroderma	0.000167	0.000167	CcSEcCtD
Cevimeline—Body temperature increased—Prednisone—systemic scleroderma	0.000167	0.000167	CcSEcCtD
Cevimeline—Hypotension—Methotrexate—systemic scleroderma	0.000165	0.000165	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000161	0.000161	CcSEcCtD
Cevimeline—Insomnia—Methotrexate—systemic scleroderma	0.00016	0.00016	CcSEcCtD
Cevimeline—Paraesthesia—Methotrexate—systemic scleroderma	0.000159	0.000159	CcSEcCtD
Cevimeline—Dyspnoea—Methotrexate—systemic scleroderma	0.000158	0.000158	CcSEcCtD
Cevimeline—Somnolence—Methotrexate—systemic scleroderma	0.000157	0.000157	CcSEcCtD
Cevimeline—Hypersensitivity—Prednisone—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Cevimeline—Dyspepsia—Methotrexate—systemic scleroderma	0.000156	0.000156	CcSEcCtD
Cevimeline—Decreased appetite—Methotrexate—systemic scleroderma	0.000154	0.000154	CcSEcCtD
Cevimeline—Fatigue—Methotrexate—systemic scleroderma	0.000153	0.000153	CcSEcCtD
Cevimeline—Asthenia—Prednisone—systemic scleroderma	0.000152	0.000152	CcSEcCtD
Cevimeline—Pain—Methotrexate—systemic scleroderma	0.000151	0.000151	CcSEcCtD
Cevimeline—Pruritus—Prednisone—systemic scleroderma	0.00015	0.00015	CcSEcCtD
Cevimeline—Feeling abnormal—Methotrexate—systemic scleroderma	0.000146	0.000146	CcSEcCtD
Cevimeline—Diarrhoea—Prednisone—systemic scleroderma	0.000145	0.000145	CcSEcCtD
Cevimeline—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000145	0.000145	CcSEcCtD
Cevimeline—Urticaria—Methotrexate—systemic scleroderma	0.000141	0.000141	CcSEcCtD
Cevimeline—Dizziness—Prednisone—systemic scleroderma	0.00014	0.00014	CcSEcCtD
Cevimeline—Abdominal pain—Methotrexate—systemic scleroderma	0.00014	0.00014	CcSEcCtD
Cevimeline—Body temperature increased—Methotrexate—systemic scleroderma	0.00014	0.00014	CcSEcCtD
Cevimeline—Vomiting—Prednisone—systemic scleroderma	0.000135	0.000135	CcSEcCtD
Cevimeline—Rash—Prednisone—systemic scleroderma	0.000134	0.000134	CcSEcCtD
Cevimeline—Dermatitis—Prednisone—systemic scleroderma	0.000133	0.000133	CcSEcCtD
Cevimeline—Headache—Prednisone—systemic scleroderma	0.000133	0.000133	CcSEcCtD
Cevimeline—Hypersensitivity—Methotrexate—systemic scleroderma	0.00013	0.00013	CcSEcCtD
Cevimeline—Asthenia—Methotrexate—systemic scleroderma	0.000127	0.000127	CcSEcCtD
Cevimeline—Nausea—Prednisone—systemic scleroderma	0.000126	0.000126	CcSEcCtD
Cevimeline—Pruritus—Methotrexate—systemic scleroderma	0.000125	0.000125	CcSEcCtD
Cevimeline—Diarrhoea—Methotrexate—systemic scleroderma	0.000121	0.000121	CcSEcCtD
Cevimeline—Dizziness—Methotrexate—systemic scleroderma	0.000117	0.000117	CcSEcCtD
Cevimeline—Vomiting—Methotrexate—systemic scleroderma	0.000113	0.000113	CcSEcCtD
Cevimeline—Rash—Methotrexate—systemic scleroderma	0.000112	0.000112	CcSEcCtD
Cevimeline—Dermatitis—Methotrexate—systemic scleroderma	0.000112	0.000112	CcSEcCtD
Cevimeline—Headache—Methotrexate—systemic scleroderma	0.000111	0.000111	CcSEcCtD
Cevimeline—Nausea—Methotrexate—systemic scleroderma	0.000105	0.000105	CcSEcCtD
